leisure time -WSS

leisure time

author：fashion 2025-09-03 03:30:47 - browse：741

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Supreme Court strikes down use of affirmative action
Next article： Abortion pill Supreme Court ruling could impact entire drug industry

WSS

Abortion pill case raises question: who can sue the FDA?

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Abortion pill Supreme Court ruling could impact entire drug industry

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Steward Health Care has deal to sell doctor network to UnitedHealth

Steward Health Care has deal to sell doctor network to UnitedHealth

leisure time

leisure time

Sign up for Morning Rounds

knowledge

Cancer drug shortages should be causing more outrage

Stanford president’s abrupt resignation sparks debate

Virginia high school admissions case could be legal follow

In rare move, senator releases unverified FBI source report alleging Biden bribe

Duchenne breakthrough therapy leaves behind pioneering families

Telehealth startups are trying to fill the menopause care vacuum

Medicare proposal to cover medical devices draws a mixed reaction

Abortion pill Supreme Court ruling could impact entire drug industry

Virginia high school admissions case could be legal follow

The Readout: Lenmeldy, GLP

explore

Primary care physicians play key roles in Alzheimer's management

Patient advocates debate FDA's accelerated approval process

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Stanford president’s abrupt resignation sparks debate

Mystery swirls around US soldier who entered North Korea days ago, officials say

Will generative AI in health care meet the fate of IBM's Dr. Watson?

focus

explore

hotspot

hotspot